VBIO
Valion Bio, Inc.Company with tickers: TIVC
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $5,634,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Research & Development | $1,854,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Operating Income | $-5,634,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Net Income | $-6,202,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Basic) | $-2.23 | USD/shares | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Diluted) | — |
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
By Product & Service (USD)
| Component | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|
| Shipping And Handling | $5,000 | $3,000 | $3,000 | $1,000 |